As we thoroughly collate and evaluate three years of studying GLP-1 obesity drug trends among real-world populations, new patterns are emerging that help us understand how these drugs are being used and how external factors may be impacting persistence and health outcomes, said Pat Gleason, PharmD, assistant vice president, health outcomes, at Prime
The tennis star who has won the Grand Slam and Olympic gold medals many times over recently shared that she's teamed up with Ro, a telehealth company, as both a patient and an ambassador
Whether you stay on it, reduce your dose with your doctor, or eventually stop, we want to make sure that when that day comes, you're ready
Anyone presenting BPC-157 as a proven human therapy is overstating the evidence
Discount codes apply automatically